Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$307.80 USD

307.80
3,427,831

+6.66 (2.21%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $307.00 -0.80 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (175 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Pra Health Grows Organically, Symphony Synergies a Positive

by Zacks Equity Research

The $530-million Symphony buyout buoys hope for PRA Health (PRAH). The move is likely to improve its ability in the clinical research and commercial development process via data and analytics tools.

    Zacks Equity Research

    Here's Why You Must Add STERIS (STE) to Your Portfolio Now

    by Zacks Equity Research

    STERIS' (STE) acquisition of U.K.-based outsourced sterilization services provider, Synergy Health plc, remains one of its key strategic moves.

      Zacks Equity Research

      Medical Device Firms in Focus on Expanded R&D Scope: 5 Picks

      by Zacks Equity Research

      The suspension of the Medical Device Tax, the evolution of mechatronics and big data in the MedTech space make some of the stocks lucrative picks for investment.

        Zacks Equity Research

        Opko Health (OPK) Rallies on Q1 Earnings and Revenue Beat

        by Zacks Equity Research

        Opko Health (OPK) gains from solid pharmaceutical business in the first quarter of 2018.

          Zacks Equity Research

          IDEXX Laboratories Global Growth Solid on Catalyst Uptake

          by Zacks Equity Research

          IDEXX (IDXX) steadily demonstrates strong organic growth, driven by solid sales at the Companion Animal Group (CAG) business, fueled by a firm global Catalyst uptake.

            Zacks Equity Research

            New Indication for Medtronic's Bone Cement Gets 510(K) Nod

            by Zacks Equity Research

            Medtronic (MDT) to broaden its commitment to the therapy of pathological fractures of the vertebral body on the back of its expanded indication for Kyphon HV-R Bone Cement.

              Zacks Equity Research

              Medtronic Gets Expanded FDA Nod for MiniMed 670G System

              by Zacks Equity Research

              Medtronic (MDT) continues to adopt initiatives to bolster the Diabetes segment.

                Zacks Equity Research

                Here's Why You Should Hold Merit Medical (MMSI) Stock Now

                by Zacks Equity Research

                Here we take a quick look at the major factors that plague Merit Medical (MMSI) and discuss the prospects that ensure near-term recovery.

                  Zacks Equity Research

                  Here's Why You Should Buy Integra LifeSciences (IART) Stock

                  by Zacks Equity Research

                  Integra LifeSciences' (IART) key developments on the overseas front buoy optimism on the stock among investors.

                    Zacks Equity Research

                    Accuray's Radixact Gets AERB Nod in India, Prospects Solid

                    by Zacks Equity Research

                    The Atomic Energy Regulatory Board (AERB) approves Accuray's (ARAY) Radixact X9 in India; exposes the company to AI and Mechatronic trends.